octreotide
UkraineDrugs containing this active substance
-
The drug is used to control the symptoms of acromegaly (lowering growth hormone levels), to alleviate conditions in endocrine tumors of the gastrointestinal tract and pancreas, to prevent complications after pancreatic surgery, and to stop and prevent recurrent bleeding from esophageal and gastric veins in liver cirrhosis.
Form: solution for injection
Active substance Dosage octreotide 0.1 mg/ml ATC: H01CB02
Manufacturer: Farmak JSC
-
The drug is used to control the manifestations of acromegaly (lowering growth hormone levels), alleviate the symptoms of endocrine tumors of the gastrointestinal tract and pancreas, prevent complications after pancreatic surgery, and to stop bleeding from esophageal and gastric varices in patients with liver cirrhosis.
Form: solution for injection and infusion
Active substance Dosage octreotide 0.1 mg/ml ATC: H01CB02
-
The drug is used to control the manifestations of acromegaly (reduction of growth hormone levels), alleviate the symptoms of endocrine tumors of the gastrointestinal tract and pancreas, as well as for the prevention of complications after pancreatic surgery and the management of bleeding in esophageal varices.
Form: solution for injection
Active substance Dosage octreotide 0.05 mg/ml ATC: H01CB02
Manufacturer: Bendalis GmbH (manufacturer responsible for batch release)
-
The drug is used to control the symptoms of acromegaly (lowering growth hormone levels), to alleviate the condition in endocrine tumors of the gastrointestinal tract and pancreas, and to stop bleeding from the veins of the esophagus and stomach in cases of liver cirrhosis.
Form: solution for injection
Active substance Dosage octreotide 0.1 mg/ml ATC: H01CB02
Manufacturer: Bendalis GmbH (manufacturer responsible for batch release)
-
The drug is used to control the manifestations of acromegaly (lowering growth hormone levels), alleviate symptoms of endocrine tumors of the gastrointestinal tract and pancreas, prevent complications after pancreatic surgery, and to stop bleeding from the veins of the esophagus and stomach in cases of liver cirrhosis.
Form: solution for injection
Active substance Dosage octreotide 0.5 mg/ml ATC: H01CB02
Manufacturer: Bendalis GmbH (manufacturer responsible for batch release)
-
The drug is used for the treatment of acromegaly, as well as for the control of symptoms of endocrine tumors of the gastrointestinal tract and pancreas (e.g., carcinoid tumors, insulinomas, glucagonomas, and others).
Form: powder for injection suspension
Active substance Dosage octreotide 10 mg ATC: H01CB02
Manufacturer: Novartis Pharma Stein AG (secondary packaging, batch release of finished product)
-
The drug is used to treat acromegaly, as well as the symptoms of certain endocrine tumors of the gastrointestinal tract and pancreas (e.g., carcinoid tumors, glucagonomas, insulinomas, gastrinomas, etc.).
Form: powder for injection suspension
Active substance Dosage octreotide 20 mg ATC: H01CB02
Manufacturer: Novartis Pharma Stein AG (secondary packaging, batch release of finished product)
-
The drug is used to treat acromegaly, as well as to control the symptoms of endocrine tumors of the gastrointestinal tract and pancreas (e.g., carcinoid tumors, insulinomas, glucagonomas, and others).
Form: powder for injection suspension
Active substance Dosage octreotide 30 mg ATC: H01CB02
Manufacturer: Novartis Pharma Stein AG (secondary packaging, batch release of finished product)